242 filings
Page 3 of 13
8-K
ww6hd
7 Apr 22
CytoSorbents Receives Approximately $740,000 from the New Jersey Business Tax Certificate Transfer Program
4:30pm
8-K
cv6ff
5 Apr 22
CytoSorbents Appoints Jiny Kim, MBA to its Board of Directors
4:30pm
8-K
vjipc3ter4vlc0chi
17 Mar 22
Other Events
4:31pm
8-K
6uynyu2etlxabl
8 Mar 22
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and 2021 total revenue was $43.2 million, including product sales of $40.1 million. Core
5:15pm
8-K
lil2de 9pfvzjlsc
1 Feb 22
Other Events
4:31pm
8-K
d7ltptmcxaj36v q6y
24 Jan 22
Other Events
4:30pm
8-K
emvg 6bjpmw7xcxlx3p
20 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
yn7 5rg95698k6kvgh1c
18 Jan 22
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
4:30pm
8-K
5qlja i83814efnozkm
30 Dec 21
Entry into a Material Definitive Agreement
5:28pm
8-K
sy4p3v9po
21 Dec 21
Other Events
9:00am
8-K
ned835rs1p e3k2yve8
4 Nov 21
CytoSorbents Reports Full Third Quarter 2021 Financial and Third Quarter 2021 total revenue was $9.8 million, including product sales of $8.9
4:49pm
8-K
sxaps9jk
21 Oct 21
CytoSorbents Comments on REMOVE Study Presentation
6:01am
8-K
9cvusi9i9vi7xv 126b6
15 Oct 21
Other Events
12:00am
8-K
udwzs
13 Oct 21
CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance
7:00am
8-K
k41l0oopz
8 Oct 21
Other Events
7:31am
8-K
rymnaw
14 Sep 21
CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19
5:00pm
8-K
kygsakjyyhags
10 Sep 21
Other Events
4:32pm
8-K
zmakjxur0ixhdkpokwa
1 Sep 21
Other Events
5:27pm
8-K
1kexaq7vd9mcg t4w
12 Aug 21
Other Events
4:05pm
8-K
a6f07bud2cc0
4 Aug 21
CytoSorbents Reports Second Quarter 2021 Financial and Second Quarter 2021 Financial Highlights
12:00am